Literature DB >> 5529472

Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa.

R E Barrett, M D Yahr, R C Duvoisin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5529472     DOI： 10.1212/wnl.20.11_part_2.107

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Drug treatment of diseases characterized by abnormal movements.

Authors:  C D Marsden
Journal:  Proc R Soc Med       Date:  1973-09

Review 4.  Spasmodic torticollis: a behavioral perspective.

Authors:  P R Martin
Journal:  J Behav Med       Date:  1982-06

5.  The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.

Authors:  Friederike Sixel-Döring; Knut Liepe; Brit Mollenhauer; Ellen Trautmann; Claudia Trenkwalder
Journal:  J Neurol       Date:  2011-05-06       Impact factor: 4.849

Review 6.  Treatment strategies for dystonia.

Authors:  Leslie J Cloud; H A Jinnah
Journal:  Expert Opin Pharmacother       Date:  2010-01       Impact factor: 3.889

Review 7.  Animal models for dystonia.

Authors:  Bethany K Wilson; Ellen J Hess
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

8.  Idiopathic dystonia: neuropharmacological study.

Authors:  F Girotti; G Scigliano; N Nardocci; L Angelini; G Broggi; P Giovannini; T Caraceni
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

Review 9.  How Many Dystonias? Clinical Evidence.

Authors:  Alberto Albanese
Journal:  Front Neurol       Date:  2017-02-03       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.